phenylbutazone has been researched along with Anemia, Sickle Cell in 1 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KE | 1 |
| Peterson, CM | 1 |
| Alvares, AP | 1 |
| Kappas, A | 1 |
1 other study available for phenylbutazone and Anemia, Sickle Cell
| Article | Year |
|---|---|
Oxidative drug metabolism and inducibility by phenobarbital in sickle cell anemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antipyrine; Female; Half-Life; Humans; Male; Metabolic Clear | 1977 |